References
- Zhang H, Gao C, Fang L, Zhao HC, Yao SK. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis. Scand J Gastroenterol 2013;48:78–87.
- Shank JJ, Yang K, Ghannam J, Metformin targets ovarian cancer stem cells in vitro and in vivo. Gynecol Oncol 2012;127:390–7.
- Wu B, Li S, Sheng L, Metformin inhibits the development and metastasis of ovarian cancer. Oncol Rep 2012;28:903–8.
- Chan DK, Miskimins WK. Metformin and phenethyl isothiocyanate combined treatment in vitro is cytotoxic to ovarian cancer cultures. J Ovarian Res 2012;5:19.
- Xiao X, He Q, Lu C, Metformin impairs the growth of liver kinase B1-intact cervical cancer cells. Gynecol Oncol 2012;127:249–55.
- Dong L, Zhou Q, Zhang Z, Zhu Y, Duan T, Feng Y. Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression. J Obstet Gynaecol Res 2012;38:1077–85.
- Lee JH, Jeon SM, Hong SP, Cheon JH, Kim TI, Kim WH. Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer. Dig Liver Dis 2012.
- Chaiteerakij R, Yang JD, Harmsen WS, Risk factors for intrahepatic cholangiocarcinoma: Association between metformin use and reduced cancer risk. Hepatology 2012.
- Mazzone PJ, Rai H, Beukemann M, Xu M, Jain AK, Sasidhar M. The effect of metformin and thiazolidinedione use on lung cancer in diabetics. BMC Cancer 2012;12:410.
- Ashinuma H, Takiguchi Y, Kitazono S, Antiproliferative action of metformin in human lung cancer cell lines. Oncol Rep 2012;28:8–14.
- Colquhoun AJ, Venier NA, Vandersluis AD, Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer. Prostate Cancer Prostatic Dis 2012.